Scout | Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

This grant opportunity aims to support innovative research for precision probiotic interventions through a two-phase award (R61/R33). The goal is to understand person-specific factors affecting probiotic responses and to improve clinical outcomes. The first phase (R61) offers up to 2 years of funding to identify unique biological patterns in individuals that affect probiotic effectiveness, usi…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: June 17, 2024

Open for Submission: June 17, 2024

Submission Deadline: June 2, 2027

Application Window Closes: June 2, 2027

Keywords

precision probiotic therapies

mechanistic research

R61/R33 Phased Innovation Award

probiotic responders

clinical outcomes

host biological patterns

probiotic clinical effects

human heterogeneity

microbiome studies

milestone-driven award

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers